The company will not receive any proceeds from the sale of shares of common stock by the selling stockholders.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEXX:
- Lexaria Bioscience Expands Strategic Outreach and Secures New Patents
- Lexaria Bioscience engages advisory firm to identify new business opportunities
- Lexaria Bioscience Secures $4 Million for R&D Expansion
- Lexaria Bioscience announces $4M registered direct offering priced ATM
- Lexaria Bioscience prices 2.7M shares at $1.50 in registered direct offering